Skip to main content
. 2017 Jul 10;12(7):e0179472. doi: 10.1371/journal.pone.0179472

Fig 1. Subgroup analysis for the risk for pneumonia from different BZRA types stratified by recency.

Fig 1

BZDs, benzodiazepine; BZRAs, benzodiazepine receptor agonists; NA, not available. ap-value <0.05.